Inovio Pharmaceuticals Inc. has granted a stock option award to a newly hired employee under its 2022 Inducement Plan. The option allows the purchase of 1,302 shares of Inovio common stock at an exercise price of $2.34 per share, the closing price on September 30, 2025. The stock option will vest over three years, with one-third of the shares vesting on each anniversary of the grant date, contingent on continued employment.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inovio Pharmaceuticals Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: PH88985) on October 02, 2025, and is solely responsible for the information contained therein.